Medisolv, a leader in healthcare quality data management, acquires Lilac Software to enhance AI analytics and support value-based care initiatives. Discover more!

Explore the impact of Pharmacy Benefit Managers on insurance premiums and drug pricing, and the regulatory insights from Abby Alpert's recent study.

Eli Lilly's latest announcement on Medicare drug plans highlights the $50 cap on expenses for weight-loss medications. Learn more about the implications.

CMS aims to enhance organ transplant transparency, improving kidney transplant rates by engaging patients and streamlining information via the IOTA Model. Take action.

Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.

Explore key trends in healthcare spending, telehealth adoption, and AI integration for clinicians to adapt strategic plans and improve patient care.

Explore how investigative journalism uncovered questionable Medicare Advantage billing practices by major insurers, highlighting significant financial and patient risks.

Explore the significance of AI in hospital billing practices highlighted in a Blue Cross Blue Shield report, analyzing impacts on maternity admissions and more.

Explore the new Ambulatory Specialty Model by CMS, focusing on value-based reimbursement for cardiologists in heart failure care. Learn its implications and requirements.

Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.